# Fluorescence Enhanced Stereotactic Surgery (FESS)

> **NCT07286903** · — · RECRUITING · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 20 (estimated)

## Conditions studied

- High Grade Glioma
- High Grade Glioma (III or IV)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07286903
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- Federico II University

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07286903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07286903, "Fluorescence Enhanced Stereotactic Surgery (FESS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07286903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*